Latest It Compliance News

Winchester Energy Limited’s shares have been suspended from ASX trading due to a failure to meet director requirements under the Corporations Act, raising questions about its governance and future compliance.

Macarthur Minerals has clarified the timing of its entitlement offer, confirming the securities issue date as 7 August 2025 with ASX quotation expected the following day. The company also reaffirmed its substantial iron ore resources at Lake Giles, maintaining investor confidence ahead of the capital raise.

Rimfire Pacific Mining Limited has had its trading suspension lifted immediately following the release of its capital raising results, signaling renewed market activity.

Latrobe Magnesium Limited has addressed ASX concerns over recent share price and volume spikes, attributing the market activity to recognition of its asset value and the imminent start of its demonstration plant.

Antares Metals has released an updated investor presentation detailing its Queens Gift Project's historical resource and highlighting promising copper and uranium exploration targets in the prolific Mt Isa region.

Macarthur Minerals has updated its rights issue prospectus, introducing a cap on the underwriter's shareholding and revising key offer terms. These changes aim to balance funding needs with shareholder control and regulatory compliance.

Emerald Resources NL has reported a substantial increase in gold mineral resources at its Memot and Dingo Range projects, advancing its goal to become a multi-mine gold producer.

Paladin Energy reported a $18.4 million operating cash outflow in Q2 2025 but maintains a strong liquidity position with $89 million in cash and $139 million in total available funding.

Astron Corporation has released updated economics for its Donald Rare Earth and Mineral Sands Project, showcasing robust financial metrics and targeting a Final Investment Decision by late 2025 with production slated for 2027.

Nyrada Inc. is set to launch a Phase IIa clinical trial of Xolatryp™, aiming to reduce heart muscle damage in acute myocardial infarction patients undergoing PCI. The trial, planned for early 2026, follows promising Phase I safety results and strong preclinical cardioprotection data.

Hutchison Telecommunications (Australia) Limited has been suspended from ASX trading following compulsory acquisition notices issued by its Amsterdam-based parent company.

Amotiv Limited reports a slight decline in EBITA for FY25 alongside a significant non-cash impairment on its APG business, reflecting a cautious outlook amid challenging market conditions.